Evaluating the efficacy of intranasal oxytocin on pain and function among individuals who experience chronic pain: a protocol for a multisite, placebo-controlled, blinded, sequential, within-subjects crossover trial
Guardado en:
Autores principales: | David Flusk, Lynn Cooper, Maryam Nasr-Esfahani, Aaron MacInnes, Yanqing Yi, Joshua A. Rash, Tavis S. Campbell, Anastasia A. Mekhael, Patricia A. Poulin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ee7cdedcbf84031a0b083d96fa4bb96 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intranasal oxytocin drives coordinated social approach
por: Patrick K. Monari, et al.
Publicado: (2021) -
Maternal speech decreases pain scores and increases oxytocin levels in preterm infants during painful procedures
por: Manuela Filippa, et al.
Publicado: (2021) -
Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques
por: M. R. Lee, et al.
Publicado: (2020) -
Efficacy of interrupted cyclic treatment with prednisolone on cancer pain: a randomized crossover study
por: Mohamed A. Ghanem
Publicado: (2021) -
Brain and psychological determinants of placebo pill response in chronic pain patients
por: Etienne Vachon-Presseau, et al.
Publicado: (2018)